Author
Listed:
- Jia Duan
(Chinese Academy of Sciences
University of Chinese Academy of Sciences)
- Peiyu Xu
(Chinese Academy of Sciences
Massachusetts Institute of Technology)
- Xiaodong Luan
(Peking Union Medical College and Chinese Academy of Medical Sciences
Peking Union Medical College and Chinese Academy of Medical Sciences
Tsinghua University
Tsinghua University)
- Yujie Ji
(Chinese Academy of Sciences
University of Chinese Academy of Sciences)
- Xinheng He
(Chinese Academy of Sciences
University of Chinese Academy of Sciences
Chinese Academy of Sciences)
- Ning Song
(University of Chinese Academy of Sciences
Chinese Academy of Sciences)
- Qingning Yuan
(Chinese Academy of Sciences)
- Ye Jin
(Peking Union Medical College and Chinese Academy of Medical Sciences
Peking Union Medical College and Chinese Academy of Medical Sciences)
- Xi Cheng
(Chinese Academy of Sciences)
- Hualiang Jiang
(University of Chinese Academy of Sciences
Chinese Academy of Sciences
ShanghaiTech University)
- Jie Zheng
(Chinese Academy of Sciences)
- Shuyang Zhang
(Peking Union Medical College and Chinese Academy of Medical Sciences
Peking Union Medical College and Chinese Academy of Medical Sciences
Tsinghua University
Tsinghua University)
- Yi Jiang
(ShanghaiTech University
Lingang Laboratory)
- H. Eric Xu
(Chinese Academy of Sciences
University of Chinese Academy of Sciences
ShanghaiTech University)
Abstract
Thyroid-stimulating hormone (TSH), through activation of its G-protein-coupled thyrotropin receptor (TSHR), controls the synthesis of thyroid hormone—an essential metabolic hormone1–3. Aberrant signalling of TSHR by autoantibodies causes Graves’ disease (hyperthyroidism) and hypothyroidism, both of which affect millions of patients worldwide4. Here we report the active structures of TSHR with TSH and the activating autoantibody M225, both bound to the allosteric agonist ML-1096, as well as an inactivated TSHR structure with the inhibitory antibody K1-707. Both TSH and M22 push the extracellular domain (ECD) of TSHR into an upright active conformation. By contrast, K1-70 blocks TSH binding and cannot push the ECD into the upright conformation. Comparisons of the active and inactivated structures of TSHR with those of the luteinizing hormone/choriogonadotropin receptor (LHCGR) reveal a universal activation mechanism of glycoprotein hormone receptors, in which a conserved ten-residue fragment (P10) from the hinge C-terminal loop mediates ECD interactions with the TSHR transmembrane domain8. One notable feature is that there are more than 15 cholesterols surrounding TSHR, supporting its preferential location in lipid rafts9. These structures also highlight a similar ECD-push mechanism for TSH and autoantibody M22 to activate TSHR, therefore providing the molecular basis for Graves’ disease.
Suggested Citation
Jia Duan & Peiyu Xu & Xiaodong Luan & Yujie Ji & Xinheng He & Ning Song & Qingning Yuan & Ye Jin & Xi Cheng & Hualiang Jiang & Jie Zheng & Shuyang Zhang & Yi Jiang & H. Eric Xu, 2022.
"Hormone- and antibody-mediated activation of the thyrotropin receptor,"
Nature, Nature, vol. 609(7928), pages 854-859, September.
Handle:
RePEc:nat:nature:v:609:y:2022:i:7928:d:10.1038_s41586-022-05173-3
DOI: 10.1038/s41586-022-05173-3
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Citations
Citations are extracted by the
CitEc Project, subscribe to its
RSS feed for this item.
Cited by:
- Jia Duan & Peiyu Xu & Huibing Zhang & Xiaodong Luan & Jiaqi Yang & Xinheng He & Chunyou Mao & Dan-Dan Shen & Yujie Ji & Xi Cheng & Hualiang Jiang & Yi Jiang & Shuyang Zhang & Yan Zhang & H. Eric Xu, 2023.
"Mechanism of hormone and allosteric agonist mediated activation of follicle stimulating hormone receptor,"
Nature Communications, Nature, vol. 14(1), pages 1-12, December.
- Dawei Sun & Yonglian Sun & Eric Janezic & Tricia Zhou & Matthew Johnson & Caleigh Azumaya & Sigrid Noreng & Cecilia Chiu & Akiko Seki & Teresita L. Arenzana & John M. Nicoludis & Yongchang Shi & Baome, 2023.
"Structural basis of antibody inhibition and chemokine activation of the human CC chemokine receptor 8,"
Nature Communications, Nature, vol. 14(1), pages 1-13, December.
- Aika Iwama & Ryoji Kise & Hiroaki Akasaka & Fumiya K. Sano & Hidetaka S. Oshima & Asuka Inoue & Wataru Shihoya & Osamu Nureki, 2024.
"Structure and dynamics of the pyroglutamylated RF-amide peptide QRFP receptor GPR103,"
Nature Communications, Nature, vol. 15(1), pages 1-13, December.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:609:y:2022:i:7928:d:10.1038_s41586-022-05173-3. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.